Liver Function Tests Market By Enzymes 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Liver Function Tests Market
Liver Function Tests Market: By Enzymes (Aspartate Aminotransferase, Alanine Aminotransferase), By Application (Disease Activity, Investigation of Suspected Liver Disease, Blood Routine Analysis, Others) & By Region-Forecast (2016-2021)
Report Code : HCR 0335
Updated Date: 05 February, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Liver Function Tests Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Liver Function Tests Market– Market Forces
   4.1. Drivers
      4.1.1. Rising focus on research development activities in this segment
      4.1.2. Increasing prevalence of liver diseases across the globe
   4.2. Restraints
      4.2.1. Higher cost of research and development
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Liver Function Tests Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Liver Function Tests Market, By Enzymes
   6.1. Aspartate Aminotransferase (AST)
   6.2. Alanine Aminotransferase (ALT)
7. Liver Function Tests Market, By Application
   7.1. Disease Activity
   7.2. Investigation of Suspected Liver Disease
   7.3. Blood Routine Analysis
   7.4. Others
8. Liver Function Tests Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Liver Function Tests – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. Alpha Laboratories
   10.2. Biobase Group
   10.3. ELITechGroup
   10.4. Horiba Medical
   10.5. Laboratory Corporation of America Holdings
   10.6. Randox Laboratories Ltd
   10.7. Thermo Fisher Scientific Inc.
   10.8. Abbott Laboratories
   10.9. Roche Diagnostics
   10.10. Becton Dickinson & Company
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Liver function tests (LFT) are blood tests that are used to help healthcare professionals to differentiate among different types of liver disorders, detect the presence of liver disease, gauge the extent of liver damage, and follow the response to treatment. Globally, development of efficient and advance diagnostics technology, rise in the awareness among, rising focus on research development activities in this segment, increasing prevalence of liver diseases across the globe, and growing intake of alcohol are the prime growth drivers of global liver function tests market. In addition, increase in adoption of liver function tests in emerging economies such as China, India and others, will create new opportunities for global liver function tests market. However, higher cost of the research and development, and complex government approval processes are the key restraints for global liver function tests market.

 Liver Function Tests Market

Geographically North America dominated global liver function tests market, followed by Europe because of high medical reimbursement facilities, government support, and technological advancement in diagnostic devices. Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, growing prevalence of chronic diseases, rise in consumer awareness, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region.

This report identifies the global liver function tests market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global liver function tests market.

This report segments global liver function tests market on the basis of enzymes, applications, and regional market as follows:
  • Liver Function Tests Market, By Enzymes: Aspartate Aminotransferase (AST), and Alanine Aminotransferase (ALT)
  • The report has focused study on liver function tests market by basis of applications such as: Disease Activity, Investigation of Suspected Liver Disease, Blood Routine Analysis, and Others
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the liver function tests market. Some of the major companies’ profiles in detail are as follows:

  • Alpha Laboratories
  • Biobase Group
  • ELITechGroup
  • Horiba Medical
  • Laboratory Corporation of America Holdings
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports